Dental Care Clinics in Mount Olive, NC Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Lane And Associates Iv Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 315 Highway 55 West, Box 180, Mount Olive, NC 28365 Phone: 919-658-9555 Fax: 919-658-1009 |
Amy M Kimes, Dds Pa Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 236 Smith Chapel Rd, Mount Olive, NC 28365 Phone: 919-658-9511 |
Goshen Medical Center - Mount Olive Mobile Unit Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 325 Nc Highway 55 W, Mount Olive, NC 28365 Phone: 910-267-2044 |
Joseph Ray Mooring, Jr., D.d.s., P.a. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 236 Smith Chapel Rd, Mount Olive, NC 28365 Phone: 919-658-9511 Fax: 919-658-8555 |
News Archive
Sleep disorders have different symptoms and effects in men and women, study finds
A new study suggests that men and women are affected differently by sleep disorders. Results show that women are more likely than men to have more severe symptoms of depression, trouble sleeping at night, and excessive daytime sleepiness.
New York health department issues advisory on gonorrhea
In response to a recent increase in drug resistant gonorrhea, the New York Department of Health and Mental Hygiene (DOHMH) is issuing a health alert to New York City medical providers announcing alternative treatment recommendations for individuals infected with gonorrhea.
GW researcher explores successful interventions implemented outside ED to reduce existing ED use
In recent years, many groups, including policy makers and health systems, have looked for ways to reduce the number of visits to the emergency department (ED) as a way to lower costs and improve the quality of care. Research conducted by Jesse Pines, M.D., director of the Office of Clinical Practice Innovation and professor of emergency medicine at the George Washington University (GW) School of Medicine and Health Sciences, explored interventions that had been implemented outside of EDs that were designed to reduce ED use.
Positive results from exenatide phase 2 study in patients with type 2 diabetes
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
› Verified 4 days ago